Gubler, DJ. Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends in Microbiology
2002; 10: 100–103.
Wilder-Smith, A, Gubler, DJ. Geographic expansion of dengue: the impact of international travel. Medical Clinics of North America
2008; 92: 1377–1390.
Wilder-Smith, A, et al.
Update on dengue: epidemiology, virus evolution, antiviral drugs, and vaccine development. Current Infectious Diseases Report
2010; 12: 157–164.
Heintzem, C, Velasco Garrido, M, Kroeger, A. What do community-based dengue control programmes achieve? A systematic review of published evaluations. Transactions of the Royal Society of Tropical Medicine and Hygiene
2007; 101: 317–325.
Heggenhougen, K, Hackethal, V, Vivek, P. The behavioural and social aspects of malaria and its control. WHO Special Programme for Research and Training in Tropical Diseases (TDR), Geneva, 2003, TDR/STR/SEB/VOL/031.
Kay, BH, et al.
Control of Aedes vectors of dengue in three provinces of Vietnam by use of Mesocyclops (Copepoda) and community-based methods validated by entomologic, clinical, and serological surveillance. American Journal of Tropical Medicine and Hygiene
2002; 66: 40–48.
Chao, DL, et al.
Controlling dengue with vaccines in Thailand. PLoS Neglected Tropical Diseases
2012; 6: e1876.
Amaku, M, Coudeville, L, Massad, E. Designing a vaccination strategy against dengue. Revista do Instituto de Medicina Tropical de Sao Paulo
54 (Suppl. 18): S18–S21.
Perez, Gonzalez K, Domingo, SA, Hartnoll, R. Prevalence of human immunodeficiency virus and risk behaviours among opioid users in an emergency room. Gaelic Sanitatis
1999; 13: 7–15.
Massad, E, et al.
Modeling the impact of imperfect HIV vaccines on the incidence of the infection. Mathematical and Computer Modelling
2001; 34: 345–351.
Buchbinder, S. (1999) Studying the volunteers who make HIV vaccine trials possible, IAVI Report
Burattini, MN, et al.
Modelling the control strategies against dengue in Singapore. Epidemiology and Infection
2008; 136: 309–319.
Coutinho, FAB, et al.
Threshold conditions for a non-autonomous epidemic system describing the population dynamics of dengue. Bulletin of Mathematical Biology
2006; 68: 2263–2282.
Lopez, LF, et al.
Threshold conditions for infection persistence in complex host-vector interactions. Compte Rendus Biologies
2002; 325: 1073–1084.
Yasuno, M, Tonn, RJ. A study of biting habits of Aedes aegypti in Bangkok, Thailand. Bulletin of the World Health Organization
1970; 43: 319–325.
Bland, M. An Introduction to Medical Statistics, 3rd edn. Oxford: Oxford University Press, 2000.
Massad, E, Burattini, MN, Ortega, NRS. Fuzzy logic and measles vaccination: designing a control strategy. International Journal of Epidemiology
1999; 28: 550–557.
Azevedo, Neto RS, et al. (1994). Rubella seroepidemiology in a non-immunized population of São Paulo State, Brazil. Epidemiology and Infections
Moreno, ES and the Yellow Fever Working Group. Reemergence of yellow fever: detection of transmission in the state of São Paulo, Brazil. Revista da Sociedade Brasileira de Medicina Tropical
2011; 44: 290–296.
Leo, YS, et al.
Immunogenicity and safety of recombinant tetravalent dengue vaccine (CYD-TDV) in individuals aged 2–45 y. Phase II randomized controlled trial in Singapore. Human Vaccines & Immunotherapeutics
2012; 8: 1259–1271.
Kanesa-thasan, N, et al.
Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers. Vaccine
2001; 19: 3179–3188.
Sabchareon, A, et al.
Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial. Lancet
2012; 380: 1559–1567.